New Key Statistics Module, Z-Score and F-Score
NYSE:HAE Key Ratios
Market Cap $ M | 4,332.20 |
Enterprise Value $ M | 4,898.15 |
P/E(ttm) | 37.21 |
PE Ratio without NRI | 28.94 |
Forward PE Ratio | 18.52 |
Price/Book | 4.51 |
Price/Sales | 3.32 |
Price/Free Cash Flow | 37.93 |
Price/Owner Earnings | 55.95 |
Payout Ratio % | -- |
Revenue (TTM) $ M | 1,309.00 |
EPS (TTM) $ | 2.29 |
Beneish M-Score | -2.4 |
10-y EBITDA Growth Rate % | 12.10 |
5-y EBITDA Growth Rate % | 6.50 |
y-y EBITDA Growth Rate % | 5.20 |
EV-to-EBIT | 29.71 |
EV-to-EBITDA | 18.69 |
PEG | 4.45 |
Shares Outstanding M | 50.84 |
Net Margin (%) | 8.98 |
Operating Margin % | 13.24 |
Pre-tax Margin (%) | 11.60 |
Quick Ratio | 1.50 |
Current Ratio | 2.56 |
ROA % (ttm) | 5.70 |
ROE % (ttm) | 13.12 |
ROIC % (ttm) | 8.01 |
Dividend Yield % | -- |
Altman Z-Score | 3.41 |
HAE Number of Guru Trades
HAE Volume of Guru Trades
Gurus Latest Trades with NYSE:HAE
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NYSE:HAE is held by these investors
Total 3
Haemonetics Corp Insider Transactions
No Available Data
News about NYSE:HAE
Total 0- 1